The Clorox Company (NYSE:CLX) Shares Purchased by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT boosted its stake in The Clorox Company (NYSE:CLX) by 69.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,399 shares of the company’s stock after acquiring an additional 983 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Clorox were worth $390,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. Brooklyn Investment Group grew its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox in the 3rd quarter valued at $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc acquired a new stake in Clorox during the 4th quarter worth $32,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in Clorox during the 3rd quarter worth $54,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent research reports. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Stock Up 2.8 %

Shares of CLX opened at $157.41 on Friday. The firm has a market cap of $19.39 billion, a P/E ratio of 43.01, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company’s 50-day moving average price is $157.72 and its 200 day moving average price is $159.73. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 EPS. On average, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.